Andrew Henry

Humanization of murine monoclonal antibodies through variable domain resurfacing.

Michael Roguska, Jim Thuesen Pedersen, C Keddy et al. · Proceedings of the National Academy of Sciences · 1994 · 201 citations · Full text

Antibody-antigen interactions

David M. Webster, Andrew Henry, Anthony R. Rees · Current Opinion in Structural Biology · 1994 · 132 citations

Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials

Joachim Drevs, Ute Zirrgiebel, C. Schmidt-Gersbach et al. · Annals of Oncology · 2005 · 120 citations

Tyrosine Kinase Inhibitor, Medicine, Receptor Tyrosine Kinase +8

Reduced antibody response to streptavidin through site‐directed mutagenesis

Damon L. Meyer, Jody Schultz, Yukang Lin et al. · Protein Science · 2001 · 70 citations · Full text

A comparison of two murine monoclonal antibodies humanized by CDR-grafting and variable domain resurfacing

Michael Roguska, Jan T. Pedersen, Andrew Henry et al. · Protein Engineering Design and Selection · 1996 · 67 citations · Full text